HERPES VIRUS (HHV 2) - ANVISA Registration 10339840513

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10339840513 and manufactured by DIASORIN MOLECULAR LLC. The registration is held by DIASORIN LTDA with validity until Sep 02, 2029.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASORIN ITALIA S.P.A., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10339840513
2 Related Devices
Registration Details
ANVISA Registration Number: 10339840513
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Simplexa™ HSV 1 & 2 Direct
Risk Class III

Registration Details

10339840513

25351810151201857

01896764000170

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 02, 2019

02/09/2029

09/18/2025 19:00:01

Simplexa™ HSV 1 & 2 Direct
Risk Class III

Registration Details

10339840513

25351810151201857

01896764000170

Company Information

Dates and Status

Sep 02, 2019

02/09/2029

09/18/2025 19:00:01